Samir Kaul - 05 May 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role: Director
Signature: /s/ John J. Demeter, as attorney-in-fact for Samir Kaul
Issuer symbol: GH
Transactions as of: 05 May 2021
Transactions value $: -$714,242
Form type: 4
Filing time: 07 May 2021, 16:41:39 UTC
Next filing: 21 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GH	COMMON STOCK	Sale	-$181,351	-1,295	-6.49%	$140.04^*	18,648	05 May 2021	By Trust	F1, F2, F3
transaction	GH	COMMON STOCK	Sale	-$42,492	-300	-1.61%	$141.64^*	18,348	05 May 2021	By Trust	F1, F3, F4
transaction	GH	COMMON STOCK	Sale	-$71,310	-500	-2.73%	$142.62^*	17,848	05 May 2021	By Trust	F1, F3, F5
transaction	GH	COMMON STOCK	Sale	-$201,603	-1,405	-7.87%	$143.49^*	16,443	05 May 2021	By Trust	F1, F3, F6
transaction	GH	COMMON STOCK	Sale	-$130,050	-900	-5.47%	$144.5^*	15,543	05 May 2021	By Trust	F1, F3, F7
transaction	GH	COMMON STOCK	Sale	-$43,554	-300	-1.93%	$145.18^*	15,243	05 May 2021	By Trust	F1, F3, F8
transaction	GH	COMMON STOCK	Sale	-$43,881	-300	-1.97%	$146.27^*	14,943	05 May 2021	By Trust	F1, F3, F9
holding	GH	COMMON STOCK						4,059	05 May 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.63 to $140.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within each of the ranges set forth in this Form.
F3	Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.99 to $141.98 inclusive.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.04 to $143.03 inclusive.
F6	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.07 to $144.01 inclusive.
F7	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.10 to $144.85 inclusive.
F8	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.10 to $145.29 inclusive.
F9	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.10 to $146.40 inclusive.